This report contains market size and forecasts of Varicella Vaccine in global, including the following market information:
Global Varicella Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Varicella Vaccine Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Varicella Vaccine companies in 2020 (%)
The global Varicella Vaccine market was valued at 3984.6 million in 2020 and is projected to reach US$ 5314.3 million by 2027, at a CAGR of 7.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, By Type, 2020 (%)
Injection
Freeze-Dried Powder
Global Varicella Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, By Application, 2020 (%)
Kids Injection
Adults Injection
Global Varicella Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Varicella Vaccine revenues share in global market, 2020 (%)
Key companies Varicella Vaccine sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Varicella Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Varicella Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Varicella Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Varicella Vaccine Overall Market Size
2.1 Global Varicella Vaccine Market Size: 2021 VS 2027
2.2 Global Varicella Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Varicella Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Varicella Vaccine Players in Global Market
3.2 Top Global Varicella Vaccine Companies Ranked by Revenue
3.3 Global Varicella Vaccine Revenue by Companies
3.4 Global Varicella Vaccine Sales by Companies
3.5 Global Varicella Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Varicella Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Varicella Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Varicella Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Varicella Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Varicella Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Varicella Vaccine Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Freeze-Dried Powder
4.2 By Type - Global Varicella Vaccine Revenue & Forecasts
4.2.1 By Type - Global Varicella Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Varicella Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Varicella Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Varicella Vaccine Sales & Forecasts
4.3.1 By Type - Global Varicella Vaccine Sales, 2016-2021
4.3.2 By Type - Global Varicella Vaccine Sales, 2022-2027
4.3.3 By Type - Global Varicella Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Varicella Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Varicella Vaccine Market Size, 2021 & 2027
5.1.2 Kids Injection
5.1.3 Adults Injection
5.2 By Application - Global Varicella Vaccine Revenue & Forecasts
5.2.1 By Application - Global Varicella Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Varicella Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Varicella Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Varicella Vaccine Sales & Forecasts
5.3.1 By Application - Global Varicella Vaccine Sales, 2016-2021
5.3.2 By Application - Global Varicella Vaccine Sales, 2022-2027
5.3.3 By Application - Global Varicella Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Varicella Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Varicella Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Varicella Vaccine Revenue & Forecasts
6.2.1 By Region - Global Varicella Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Varicella Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Varicella Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Varicella Vaccine Sales & Forecasts
6.3.1 By Region - Global Varicella Vaccine Sales, 2016-2021
6.3.2 By Region - Global Varicella Vaccine Sales, 2022-2027
6.3.3 By Region - Global Varicella Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Varicella Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Varicella Vaccine Sales, 2016-2027
6.4.3 US Varicella Vaccine Market Size, 2016-2027
6.4.4 Canada Varicella Vaccine Market Size, 2016-2027
6.4.5 Mexico Varicella Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Varicella Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Varicella Vaccine Sales, 2016-2027
6.5.3 Germany Varicella Vaccine Market Size, 2016-2027
6.5.4 France Varicella Vaccine Market Size, 2016-2027
6.5.5 U.K. Varicella Vaccine Market Size, 2016-2027
6.5.6 Italy Varicella Vaccine Market Size, 2016-2027
6.5.7 Russia Varicella Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Varicella Vaccine Market Size, 2016-2027
6.5.9 Benelux Varicella Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Varicella Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Varicella Vaccine Sales, 2016-2027
6.6.3 China Varicella Vaccine Market Size, 2016-2027
6.6.4 Japan Varicella Vaccine Market Size, 2016-2027
6.6.5 South Korea Varicella Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Varicella Vaccine Market Size, 2016-2027
6.6.7 India Varicella Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Varicella Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Varicella Vaccine Sales, 2016-2027
6.7.3 Brazil Varicella Vaccine Market Size, 2016-2027
6.7.4 Argentina Varicella Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Varicella Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Varicella Vaccine Sales, 2016-2027
6.8.3 Turkey Varicella Vaccine Market Size, 2016-2027
6.8.4 Israel Varicella Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Varicella Vaccine Market Size, 2016-2027
6.8.6 UAE Varicella Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Varicella Vaccine Major Product Offerings
7.1.4 Merck Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Varicella Vaccine Major Product Offerings
7.2.4 GSK Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Shanghai Institute
7.3.1 Shanghai Institute Corporate Summary
7.3.2 Shanghai Institute Business Overview
7.3.3 Shanghai Institute Varicella Vaccine Major Product Offerings
7.3.4 Shanghai Institute Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Shanghai Institute Key News
7.4 BCHT
7.4.1 BCHT Corporate Summary
7.4.2 BCHT Business Overview
7.4.3 BCHT Varicella Vaccine Major Product Offerings
7.4.4 BCHT Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 BCHT Key News
7.5 Changsheng
7.5.1 Changsheng Corporate Summary
7.5.2 Changsheng Business Overview
7.5.3 Changsheng Varicella Vaccine Major Product Offerings
7.5.4 Changsheng Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Changsheng Key News
7.6 Keygen
7.6.1 Keygen Corporate Summary
7.6.2 Keygen Business Overview
7.6.3 Keygen Varicella Vaccine Major Product Offerings
7.6.4 Keygen Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Keygen Key News
7.7 Green Cross
7.7.1 Green Cross Corporate Summary
7.7.2 Green Cross Business Overview
7.7.3 Green Cross Varicella Vaccine Major Product Offerings
7.4.4 Green Cross Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Green Cross Key News
7.8 Biken
7.8.1 Biken Corporate Summary
7.8.2 Biken Business Overview
7.8.3 Biken Varicella Vaccine Major Product Offerings
7.8.4 Biken Varicella Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Biken Key News
8 Global Varicella Vaccine Production Capacity, Analysis
8.1 Global Varicella Vaccine Production Capacity, 2016-2027
8.2 Varicella Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Varicella Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Varicella Vaccine Supply Chain Analysis
10.1 Varicella Vaccine Industry Value Chain
10.2 Varicella Vaccine Upstream Market
10.3 Varicella Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Varicella Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Varicella Vaccine in Global Market
Table 2. Top Varicella Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Varicella Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Varicella Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Varicella Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. Global Varicella Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Varicella Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Varicella Vaccine Product Type
Table 9. List of Global Tier 1 Varicella Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Varicella Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken